Skip to main content
Erschienen in: European Radiology 2/2015

01.02.2015 | Gastrointestinal

Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings

verfasst von: Riccardo Negrelli, Riccardo Manfredi, Beatrice Pedrinolla, Enrico Boninsegna, Anna Ventriglia, Sara Mehrabi, Luca Frulloni, Roberto Pozzi Mucelli

Erschienen in: European Radiology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Aim

To evaluate the magnetic resonance (MR) imaging-MR cholangiopancreatographic (MRCP) findings of focal forms of autoimmune pancreatitis (AIP) to describe ductal involvement at diagnosis.

Methods

MR examinations of 123 patients affected by AIP were analysed. We included 26 patients who satisfied International Consensus Diagnostic Criteria and were suffering from focal AIP. Image analysis included: site of parenchymal enlargement, main pancreatic duct (MPD) diameter, MPD stenosis, stricture length, presence of upstream dilation within the stricture, signal intensity, and pancreatic enhancement.

Results

Signal intensity abnormalities were localized in the head in 10/26 (38.5 %) and in the body-tail in 16/26 (61.5 %) patients. MRCP showed a single MPD stenosis in 12/26 (46.1 %) and multiple MPD stenosis in 14/26 (53.8 %) patients, without a dilation of the upstream MPD (mean: 3.83 mm). Lesions showed hypointensity on T1-weighted images in all patients, and hyperintensity on T2-weighted images in 22/26 (84.6 %) patients. The affected parenchyma was hypovascular during the arterial phase in 25/26 (96.2 %) patients with contrast retention.

Conclusions

MR-MRCP are effective techniques for the diagnosis of AIP showing the loss of the physiological lobulation and the typical contrastographic appearance. The presence of multiple, long stenoses without an upstream MPD dilation at MRCP suggests the diagnosis of AIP, and can be useful in differential diagnosis of pancreatic adenocarcinoma.

Key Points

MRI represents the gold standard in the diagnosis of AIP.
MRCP is an increasingly useful technique in the diagnosis of focal AIP.
MRCP could be a problem-solving tool in the differential diagnosis of AIP.
Literatur
1.
Zurück zum Zitat Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355:2670–2676PubMedCrossRef Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355:2670–2676PubMedCrossRef
2.
Zurück zum Zitat Manfredi R, Graziani R, Cicero C et al (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–443PubMedCrossRef Manfredi R, Graziani R, Cicero C et al (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–443PubMedCrossRef
4.
Zurück zum Zitat Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568PubMedCrossRef Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568PubMedCrossRef
5.
Zurück zum Zitat Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–436PubMedCrossRef Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–436PubMedCrossRef
6.
Zurück zum Zitat Kloppel G, Luttges J, Lohr M, Zamboni G, Longnecker D (2003) Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 27:14–19PubMedCrossRef Kloppel G, Luttges J, Lohr M, Zamboni G, Longnecker D (2003) Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 27:14–19PubMedCrossRef
7.
Zurück zum Zitat Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T (2007) Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 42:28–31PubMedCrossRef Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T (2007) Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 42:28–31PubMedCrossRef
8.
Zurück zum Zitat Zamboni G, Luttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563PubMedCrossRef Zamboni G, Luttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563PubMedCrossRef
9.
Zurück zum Zitat Frulloni L, Amodio A, Katsotourchi AM, Vantini I (2011) A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol 17:2076–2079PubMedCentralPubMedCrossRef Frulloni L, Amodio A, Katsotourchi AM, Vantini I (2011) A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol 17:2076–2079PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31:1379–1402PubMedCrossRef Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31:1379–1402PubMedCrossRef
11.
Zurück zum Zitat Frulloni L, Scattolini C, Falconi M et al (2009) Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 104:2288–2294PubMedCrossRef Frulloni L, Scattolini C, Falconi M et al (2009) Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 104:2288–2294PubMedCrossRef
12.
Zurück zum Zitat Carbognin G, Girardi V, Biasiutti C et al (2009) Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med 114:1214–1231PubMedCrossRef Carbognin G, Girardi V, Biasiutti C et al (2009) Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med 114:1214–1231PubMedCrossRef
13.
Zurück zum Zitat Chari ST, Kloeppel G, Zhang L et al (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39:549–554PubMedCrossRef Chari ST, Kloeppel G, Zhang L et al (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39:549–554PubMedCrossRef
14.
Zurück zum Zitat Chari ST, Smyrk TC, Levy MJ et al (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4:1010–1016, quiz 1934PubMedCrossRef Chari ST, Smyrk TC, Levy MJ et al (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4:1010–1016, quiz 1934PubMedCrossRef
15.
Zurück zum Zitat Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2005) Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 5:234–238, discussion 238-240PubMedCrossRef Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2005) Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 5:234–238, discussion 238-240PubMedCrossRef
16.
Zurück zum Zitat Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK (2004) Autoimmune chronic pancreatitis. Am J Gastroenterol 99:1605–1616PubMedCrossRef Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK (2004) Autoimmune chronic pancreatitis. Am J Gastroenterol 99:1605–1616PubMedCrossRef
17.
Zurück zum Zitat Sugumar A, Chari ST (2009) Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 7:S59–S62PubMedCrossRef Sugumar A, Chari ST (2009) Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 7:S59–S62PubMedCrossRef
18.
Zurück zum Zitat Sugumar A, Chari ST (2010) Diagnosis and treatment of autoimmune pancreatitis. Curr Opin Gastroenterol 26:513–518PubMedCrossRef Sugumar A, Chari ST (2010) Diagnosis and treatment of autoimmune pancreatitis. Curr Opin Gastroenterol 26:513–518PubMedCrossRef
19.
Zurück zum Zitat Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352PubMedCrossRef Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352PubMedCrossRef
20.
Zurück zum Zitat Kamisawa T, Chen PY, Tu Y et al (2006) MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol 12:2919–2922PubMedCentralPubMed Kamisawa T, Chen PY, Tu Y et al (2006) MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol 12:2919–2922PubMedCentralPubMed
21.
Zurück zum Zitat Lerch MM, Mayerle J (2011) The benefits of diagnostic ERCP in autoimmune pancreatitis. Gut 60:565–566PubMedCrossRef Lerch MM, Mayerle J (2011) The benefits of diagnostic ERCP in autoimmune pancreatitis. Gut 60:565–566PubMedCrossRef
22.
Zurück zum Zitat Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358PubMedCrossRef Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358PubMedCrossRef
23.
Zurück zum Zitat Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J (2013) Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 19:3634–3641PubMedCentralPubMedCrossRef Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J (2013) Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 19:3634–3641PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Wakabayashi T, Kawaura Y, Satomura Y et al (2003) Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98:2679–2687PubMedCrossRef Wakabayashi T, Kawaura Y, Satomura Y et al (2003) Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98:2679–2687PubMedCrossRef
25.
Zurück zum Zitat Chari ST, Takahashi N, Levy MJ et al (2009) A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7:1097–1103PubMedCrossRef Chari ST, Takahashi N, Levy MJ et al (2009) A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 7:1097–1103PubMedCrossRef
26.
Zurück zum Zitat D'Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7:257–273PubMedCrossRef D'Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7:257–273PubMedCrossRef
27.
Zurück zum Zitat Kim JH, Byun JH, Kim SY et al (2013) Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol 54:601–607PubMedCrossRef Kim JH, Byun JH, Kim SY et al (2013) Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol 54:601–607PubMedCrossRef
28.
Zurück zum Zitat Sugumar A, Chari ST (2011) Autoimmune pancreatitis. J Gastroenterol Hepatol 26:1368–1373PubMed Sugumar A, Chari ST (2011) Autoimmune pancreatitis. J Gastroenterol Hepatol 26:1368–1373PubMed
29.
Zurück zum Zitat Kamisawa T, Imai M, Yui Chen P et al (2008) Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37:e62–e67PubMedCrossRef Kamisawa T, Imai M, Yui Chen P et al (2008) Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 37:e62–e67PubMedCrossRef
30.
Zurück zum Zitat Sugumar A, Takahashi N, Chari ST (2010) Distinguishing pancreatic cancer from autoimmune pancreatitis. Curr Gastroenterol Rep 12:91–97PubMedCrossRef Sugumar A, Takahashi N, Chari ST (2010) Distinguishing pancreatic cancer from autoimmune pancreatitis. Curr Gastroenterol Rep 12:91–97PubMedCrossRef
31.
Zurück zum Zitat McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A (2001) Multi–detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMedCrossRef McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A (2001) Multi–detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220:97–102PubMedCrossRef
32.
Zurück zum Zitat Irie H, Honda H, Baba S et al (1998) Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 170:1323–1327PubMedCrossRef Irie H, Honda H, Baba S et al (1998) Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 170:1323–1327PubMedCrossRef
33.
Zurück zum Zitat Tabata T, Kamisawa T, Takuma K, Hara S, Kuruma S, Inaba Y (2012) Differences between diffuse and focal autoimmune pancreatitis. World J Gastroenterol 18:2099–2104PubMedCentralPubMedCrossRef Tabata T, Kamisawa T, Takuma K, Hara S, Kuruma S, Inaba Y (2012) Differences between diffuse and focal autoimmune pancreatitis. World J Gastroenterol 18:2099–2104PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Dechoux S, Arrive L (2011) IgG4-related sclerosing disease: autoimmune pancreatitis (AIP) and IgG4-related cholangitis. Clin Res Hepatol Gastroenterol 35:601PubMedCrossRef Dechoux S, Arrive L (2011) IgG4-related sclerosing disease: autoimmune pancreatitis (AIP) and IgG4-related cholangitis. Clin Res Hepatol Gastroenterol 35:601PubMedCrossRef
35.
Zurück zum Zitat Frulloni L, Lunardi C (2011) Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence? Dig Liver Dis 43:674–675PubMedCrossRef Frulloni L, Lunardi C (2011) Serum IgG4 in autoimmune pancreatitis: a marker of disease severity and recurrence? Dig Liver Dis 43:674–675PubMedCrossRef
36.
Zurück zum Zitat Nishino T, Toki F, Oyama H et al (2005) Biliary tract involvement in autoimmune pancreatitis. Pancreas 30:76–82PubMed Nishino T, Toki F, Oyama H et al (2005) Biliary tract involvement in autoimmune pancreatitis. Pancreas 30:76–82PubMed
37.
Zurück zum Zitat Ohara H, Nakazawa T, Ando T, Joh T (2007) Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 42:15–21PubMedCrossRef Ohara H, Nakazawa T, Ando T, Joh T (2007) Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 42:15–21PubMedCrossRef
38.
Zurück zum Zitat Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801PubMedCrossRef Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801PubMedCrossRef
Metadaten
Titel
Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings
verfasst von
Riccardo Negrelli
Riccardo Manfredi
Beatrice Pedrinolla
Enrico Boninsegna
Anna Ventriglia
Sara Mehrabi
Luca Frulloni
Roberto Pozzi Mucelli
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3371-y

Weitere Artikel der Ausgabe 2/2015

European Radiology 2/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.